David J. Herman, MD, FACP, Senior Partner at ID Care in New Jersey, discusses strategies for the diagnosis and treatment of Lyme disease and other tick-borne infections.
By Frank J. Domino, MD
It is worrisome that "high-impact" data read by most healthcare providers and then further interpreted and distributed by lay news organizations may have funder bias.
Changes in medical education and training are suggested to help new physicians address the needs of patients and their families, according to an ideas and opinions piece published in the April 22 issue of the Annals of Internal Medicine.
Participation in Substance Abuse Treatment Reduces Stimulant Use, Risky Sexual Behavior among Male HIV Patients
By Rachel Lutz
Men who are HIV-positive and enrolled in substance use treatment programs report reduced sexual risky behavior and stimulant use.
The US Food and Drug Administration has proposed a new program to provide earlier access to high-risk medical devices intended to treat or diagnose patients with serious conditions whose medical needs are not met by current technology.
Methicillin-resistant Staphylococcus aureus is now taking up residence in people's homes, according to a new study published online April 21 in the Proceedings of the National Academy of Sciences.
Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18, according to a study published in the May issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious Diseases.
By Catherine Kolonko
Company is seeking FDA approval for its all-oral, interferon-free regimen for the treatment of adult patients with chronic genotype 1 hepatitis C.
Price transparency frameworks, which provide price information presented in the context of other relevant information, should be developed to meet patients' needs, according to recommendations presented in a report from the Healthcare Financial Management Association.
By Jacquelyn Gray
By comparing variations in cykotene levels in Lyme disease patients to those in healthy subjects, researchers at John Hopkins University have pinpointed long-term complications associated with the disease.